- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 23, 2026 | 40.85M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 40.85M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 40.27M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $5K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.37M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$14.9M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $65.86M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $70.46M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $66.4M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $74.21M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $12M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.02M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $25.67M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $23.88M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $72.66M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $77.79M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $92.14M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $98.17M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.14 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.49 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.14 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.49 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.53M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $12.64M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.59M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $8.29M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5.53M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$19.65M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$6.08M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$20.6M |